Cell Type-specific MicroRNA Therapies for Myocardial Infarction
Overview
Science
Affiliations
Current interventions fail to recover injured myocardium after infarction and prompt the need for development of cardioprotective strategies. Of increasing interest is the therapeutic use of microRNAs to control gene expression through specific targeting of mRNAs. In this Review, we discuss current microRNA-based therapeutic strategies, describing the outcomes and limitations of key microRNAs with a focus on target cell types and molecular pathways. Last, we offer a perspective on the outlook of microRNA therapies for myocardial infarction, highlighting the outstanding challenges and emerging strategies.
miRNA-541-5p regulates myocardial ischemia-reperfusion injury by targeting ferroptosis.
Zhao Z, Li B, Cheng D, Leng Y J Cardiothorac Surg. 2025; 20(1):63.
PMID: 39815273 PMC: 11734549. DOI: 10.1186/s13019-024-03260-2.
Kim C, Kim H, Sim W, Jung M, Hong J, Moon S Nat Commun. 2024; 15(1):8481.
PMID: 39353987 PMC: 11445496. DOI: 10.1038/s41467-024-52812-6.
Circular RNA in Cardiovascular Diseases: Biogenesis, Function and Application.
Mei S, Ma X, Zhou L, Wuyun Q, Cai Z, Yan J Biomolecules. 2024; 14(8).
PMID: 39199340 PMC: 11352787. DOI: 10.3390/biom14080952.
A 2-decade bibliometric analysis of epigenetics of cardiovascular disease: from past to present.
Mao Y, Zhao K, Chen N, Fu Q, Zhou Y, Kong C Clin Epigenetics. 2023; 15(1):184.
PMID: 38007493 PMC: 10676610. DOI: 10.1186/s13148-023-01603-9.
MicroRNA delivery based on nanoparticles of cardiovascular diseases.
Wang N, Chen C, Ren J, Dai D Mol Cell Biochem. 2023; 479(8):1909-1923.
PMID: 37542599 DOI: 10.1007/s11010-023-04821-0.